Intrathecal onasemnogene abeparvovec in treatment-naive patients with spinal muscular atrophy: a phase 3, randomized controlled trial
A single spinal injection of onasemnogene abeparvovec significantly improved motor function in untreated spinal muscular atrophy patients, offering a promising new treatment option.